[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355375-105":59,"doc-detail-355375-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","itga8-suppresses-proliferation-and-metastasis-of-lung-adenocarcinoma-through-the-inhibition-of-glycolysis","ITGA8 suppresses proliferation and metastasis of lung adenocarcinoma through the inhibition of glycolysis","","Lung adenocarcinoma (LUAD) features high morbidity and mortality, yet the role of the integrin ITGA8 in LUAD remained unclear. Integrated bioinformatics across TCGA and GEO with clinical samples, in vitro assays, and in vivo xenografts showed ITGA8 is downregulated in LUAD and associates with advanced TNM stage, lymph node metastasis, and poor prognosis. ITGA8 overexpression suppressed proliferation, migration, invasion, and tumor growth by inhibiting aerobic glycolysis via AMPK activation and blocking the mTOR/S6K/4EBP1 axis, with AMPK inhibition reversing these effects. ITGA8 related to immune microenvironment remodeling, supporting prognostic biomarker and therapeutic target potential.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/itga8-suppresses-proliferation-and-metastasis-of-lung-adenocarcinoma-through-the-inhibition-of-glycolysis/355375/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/itga8-suppresses-proliferation-and-metastasis-of-lung-adenocarcinoma-through-the-inhibition-of-glycolysis/355375.png","ImageObject",300,407,{"name":92,"@type":93},"Jacob","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"How is ITGA8 associated with LUAD progression and patient prognosis?","Question",{"text":113,"@type":114},"ITGA8 is significantly downregulated in LUAD tissues, and low ITGA8 expression correlates with advanced TNM stage, lymph node metastasis, and poor prognosis.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What cellular and in vivo effects does ITGA8 have on LUAD?",{"text":118,"@type":114},"Overexpressing ITGA8 potently inhibits LUAD cell proliferation, migration, invasion, and xenograft tumor growth.",{"name":120,"@type":111,"acceptedAnswer":121},"Through what mechanism does ITGA8 suppress glycolysis in LUAD?",{"text":122,"@type":114},"ITGA8 suppresses aerobic glycolysis by activating AMPK signaling, which subsequently inhibits the mTOR/S6K/4EBP1 axis and reduces ECAR, glucose uptake, and lactate production.",{"name":124,"@type":111,"acceptedAnswer":125},"How does ITGA8 relate to the tumor immune microenvironment?",{"text":126,"@type":114},"ITGA8 expression positively correlates with stromal score and regulatory T cells (Tregs), while robustly negatively correlating with infiltration of myeloid-derived suppressor cells (MDSCs).","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},355375,1790785746,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":144,"language":145,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":67,"update_tm":149,"read_time":150,"preview_page_count":19,"preview_urls":151},962084931830,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nITGA8 suppresses proliferation and metastasis of lung adenocarcinoma through the inhibition of glycolysis  \nShuai-Jun Chen1,6, Xiao-Lin Cui2,6, Qian Li2, Ling-Yan Xiao3, Shan-Shan Rao1, Yu-zhi Lu4,5􀀍 & Hong-Feng Zhang1,5􀀍  \nLung adenocarcinoma (LUAD) is the most prominent subtype of non-small cell lung cancer characterized by high morbidity and mortality. While integrins are known regulators of tumor progression, most function as oncogenes; however, the role of ITGA8 in LUAD remains distinct and poorly understood. Here, we integrated bioinformatics analyses across multiple cohorts (TCGA, GEO) with experimental validation using clinical samples, in vitro assays, and in vivo xenograft models to investigate the function and mechanism of ITGA8. Unlike upregulated integrin members (e.g., ITGA2, ITGA11), ITGA8 was significantly downregulated in LUAD tissues, and its low expression correlated with advanced TNM stage, lymph node metastasis, and poor prognosis. Functionally, ITGA8 overexpression potently inhibited LUAD cell proliferation, migration, invasion, and xenograft tumor growth. Mechanistically, ITGA8 acted as a metabolic gatekeeper by suppressing aerobic glycolysis (decreasing ECAR, glucose uptake, and lactate production) via the activation of the AMPK signaling pathway and subsequent inhibition of the mTOR/S6K/4EBP1 axis. Notably, treatment with an AMPK inhibitor reversed the ITGA8-mediated suppression of glycolysis and malignant phenotypes. Furthermore, analysis of the tumor microenvironment revealed that ITGA8 expression was positively correlated with stromal score and regulatory T cells (Tregs) but robustly negatively correlated with the infiltration of myeloid-derived suppressor cells (MDSCs). Collectively, our findings establish ITGA8 as a novel tumor suppressor in LUAD that constrains malignancy by reprogramming glycolytic metabolism and remodeling the immune microenvironment, suggesting its potential as a prognostic biomarker and therapeutic target.  \nKeywords ITGA8, lung adenocarcinoma, glycolysis  \nLung cancer ranks as the most prevalent and deadly malignancy globally. Among its subtypes, non-small cell lung cancer (NSCLC) predominates, with lung adenocarcinoma (LUAD) being the most common histological variant1. Current therapeutic strategies include surgical resection, chemotherapy, radiotherapy, targeted therapy, and immunotherapy. Despite significant progress in these modalities, the prognosis for NSCLC patients remains unsatisfactory. Precision medicines targeting EGFR mutations and EML4-ALK fusions have significantly improved outcomes, yet they benefit only a specific subset (~ 30%) of LUAD patients2,3. Similarly, although immune checkpoint inhibitors (ICIs)—such as atezolizumab and pembrolizumab—have revolutionized lung cancer treatment, nearly half of patients exhibit primary resistance or develop acquired resistance during therapy4–6. Therefore, it is imperative to unravel the underlying molecular mechanisms of tumorigenesis and identify novel therapeutic targets for LUAD.  \nIntegrins are essential transmembrane receptors that orchestrate intercellular adhesion, signal transduction, and modulation of the tumor microenvironment (TME)7–10. Aberrant expression of specific integrin subunits has been implicated in the malignant progression of lung adenocarcinoma (LUAD), promoting metastasis and therapeutic resistance10–12. In LUAD, several family members, including ITGA3 and ITGB4, are typically  \n1Department of Pathology, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, China. 2Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. 3Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. 4Department of Respiratory and Cri","cbCaisk7iwUWMy3w","https://ap.wps.com/l/cbCaisk7iwUWMy3w","pdf",5760310,14,"English","# Background\n## Lung adenocarcinoma and unmet clinical needs\n## Integrins and tumor microenvironment\n# Study approach\n## Integrated bioinformatics and experimental validation\n# Findings\n## ITGA8 downregulation and clinical associations\n## Anti-tumor effects of ITGA8\n## Mechanism: glycolysis inhibition via AMPK/mTOR signaling\n## Immune microenvironment correlations\n# Conclusions\n## ITGA8 as a tumor suppressor and potential biomarker/target","[{\"question\":\"How is ITGA8 associated with LUAD progression and patient prognosis?\",\"answer\":\"ITGA8 is significantly downregulated in LUAD tissues, and low ITGA8 expression correlates with advanced TNM stage, lymph node metastasis, and poor prognosis.\"},{\"question\":\"What cellular and in vivo effects does ITGA8 have on LUAD?\",\"answer\":\"Overexpressing ITGA8 potently inhibits LUAD cell proliferation, migration, invasion, and xenograft tumor growth.\"},{\"question\":\"Through what mechanism does ITGA8 suppress glycolysis in LUAD?\",\"answer\":\"ITGA8 suppresses aerobic glycolysis by activating AMPK signaling, which subsequently inhibits the mTOR/S6K/4EBP1 axis and reduces ECAR, glucose uptake, and lactate production.\"},{\"question\":\"How does ITGA8 relate to the tumor immune microenvironment?\",\"answer\":\"ITGA8 expression positively correlates with stromal score and regulatory T cells (Tregs), while robustly negatively correlating with infiltration of myeloid-derived suppressor cells (MDSCs).\"}]","ITGA8 suppresses proliferation and metastasis of lung adenocarcinoma through the inhibition of glycolysis | PDF",1790118186,35,[152,156,160,164],{"page_no":8,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fdb6ab1a6dec8f9b699b35a0bfbfed57.webp",983,1291,{"page_no":14,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da71525d6baa4a9e362e4e5341dea76b.webp",982,1290,{"page_no":81,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd3547d4d98f1d07f07b1c2b83abcabd.webp",981,1289,{"page_no":19,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/761f44388c27c9baba2232a2d6de9e0f.webp",980,1287]